OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
Kory J. Lavine, Junedh M. Amrute, Xin Luo, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 20
Kory J. Lavine, Junedh M. Amrute, Xin Luo, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 20
Showing 20 citing articles:
Immunology of human fibrosis
Mallar Bhattacharya, Prakash Ramachandran
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1423-1433
Closed Access | Times Cited: 48
Mallar Bhattacharya, Prakash Ramachandran
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1423-1433
Closed Access | Times Cited: 48
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
From multi-omics approaches to personalized medicine in myocardial infarction
Chaoying Zhan, Tong Tang, Erman Wu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 20
Chaoying Zhan, Tong Tang, Erman Wu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 20
NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy
Stephen P. Chelko, Vinay Penna, Morgan Engel, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 10
Stephen P. Chelko, Vinay Penna, Morgan Engel, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 10
Mast cells: a novel therapeutic avenue for cardiovascular diseases?
Remo Poto, Gianni Marone, Stephen J. Galli, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 681-698
Open Access | Times Cited: 7
Remo Poto, Gianni Marone, Stephen J. Galli, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 681-698
Open Access | Times Cited: 7
Trajectory of Cardiogenic Dementia: A New Perspective
Nawaf AlRawili, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Nawaf AlRawili, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Cardiac radiation improves ventricular function in mice and humans with cardiomyopathy
Lauren N. Pedersen, Carla Valenzuela Ripoll, Mualla Özcan, et al.
Med (2023) Vol. 4, Iss. 12, pp. 928-943.e5
Open Access | Times Cited: 13
Lauren N. Pedersen, Carla Valenzuela Ripoll, Mualla Özcan, et al.
Med (2023) Vol. 4, Iss. 12, pp. 928-943.e5
Open Access | Times Cited: 13
Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases
Maya Ezzo, Boris Hinz
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108528-108528
Closed Access | Times Cited: 9
Maya Ezzo, Boris Hinz
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108528-108528
Closed Access | Times Cited: 9
Fibroblasts under pressure: cardiac fibroblast responses to hypertension and antihypertensive therapies
Upendra Chalise, Taben M. Hale
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 1, pp. H223-H237
Closed Access | Times Cited: 6
Upendra Chalise, Taben M. Hale
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 1, pp. H223-H237
Closed Access | Times Cited: 6
Mechanisms of Innate Immune Injury in Arrhythmogenic Cardiomyopathy
Stephen P. Chelko, Vinay Penna, Morgan Engel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Stephen P. Chelko, Vinay Penna, Morgan Engel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling
Xuzhe Zhang, Qin-Lin Li, Tingting Tang, et al.
JACC Basic to Translational Science (2024)
Open Access | Times Cited: 1
Xuzhe Zhang, Qin-Lin Li, Tingting Tang, et al.
JACC Basic to Translational Science (2024)
Open Access | Times Cited: 1
Transcriptomic Profiling of Human Myocardium at Sudden Death to Define Vulnerable Substrate for Lethal Arrhythmias
Arianne Caudal, Yu Liu, Paul Pang, et al.
JACC. Clinical electrophysiology (2024)
Open Access | Times Cited: 1
Arianne Caudal, Yu Liu, Paul Pang, et al.
JACC. Clinical electrophysiology (2024)
Open Access | Times Cited: 1
Spatial omics: An innovative frontier in aging research
Runsheng Chen, Shuhao Yang, Kaixu Yu, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102158-102158
Closed Access | Times Cited: 3
Runsheng Chen, Shuhao Yang, Kaixu Yu, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102158-102158
Closed Access | Times Cited: 3
RUNX1 is Expressed in a Subpopulation of Dermal Fibroblasts and Higher RUNX1 Levels are Associated with the Severity of Systemic Sclerosis
Rezvan Parvizi, Zhiyun Gong, Helen Jarnagin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rezvan Parvizi, Zhiyun Gong, Helen Jarnagin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
An epigenetic switch in macrophages promotes fibrosis in the failing heart
Alan R. Tall, Trevor P. Fidler
Nature Cardiovascular Research (2024) Vol. 3, Iss. 3, pp. 254-255
Closed Access
Alan R. Tall, Trevor P. Fidler
Nature Cardiovascular Research (2024) Vol. 3, Iss. 3, pp. 254-255
Closed Access
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases
Su Jiang, Julianna Desmarais, Cong‐Qiu Chu, et al.
Best Practice & Research Clinical Rheumatology (2024) Vol. 38, Iss. 2, pp. 101945-101945
Closed Access
Su Jiang, Julianna Desmarais, Cong‐Qiu Chu, et al.
Best Practice & Research Clinical Rheumatology (2024) Vol. 38, Iss. 2, pp. 101945-101945
Closed Access
Unraveling the Clotting Cascade in Vitamin K Deficiency Associated Comorbidities
Shalini Rajagopal, Jalaja Naravula, PB Kavi Kishor, et al.
Current Trends in Biotechnology and Pharmacy (2024) Vol. 18, Iss. 1, pp. 1608-1615
Open Access
Shalini Rajagopal, Jalaja Naravula, PB Kavi Kishor, et al.
Current Trends in Biotechnology and Pharmacy (2024) Vol. 18, Iss. 1, pp. 1608-1615
Open Access
Defining the cardiac fibroblast secretome in the healthy and infarcted mouse heart
Jasmin Bahr, Gereon Poschmann, Andreas Jungmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Jasmin Bahr, Gereon Poschmann, Andreas Jungmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
An antibody blocking IL-1 receptor accessory protein reduces cardiac inflammation and preserves heart function in viral and autoimmune myocarditis
Diego Lema, Gabriel Jakobsson, Abdel Daoud, et al.
Research Square (Research Square) (2023)
Open Access
Diego Lema, Gabriel Jakobsson, Abdel Daoud, et al.
Research Square (Research Square) (2023)
Open Access
Adipocyte Enhancer Binding Protein 1 (AEBP1) Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure.
Stavros G. Drakos, Thirupura S. Shankar, Joseph R. Visker, et al.
Research Square (Research Square) (2023)
Open Access
Stavros G. Drakos, Thirupura S. Shankar, Joseph R. Visker, et al.
Research Square (Research Square) (2023)
Open Access
